Cytotoxicity evaluation of five selected Malaysian Phyllanthaceae species on various human cancer cell lines

Journal of Medicinal Plants Research

Volumn 5, Issue 11, 2011, Pages 2267-2273

  Ramasamy, Sujatha ^a   Wahab, Norhanom Abdul ^b   Abidin, Nurhayati Zainal ^a   Manickam, Sugumaran ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Baccaurea; Cytotoxicity; Malaysia; Phyllanthaceae; Phyllanthus

Indexed keywords

ACETIC ACID ETHYL ESTER; ANTINEOPLASTIC AGENT; BACCAUREA MOTLEYANA EXTRACT; HEXANE; METHANOL; PHYLLANTHUS ACIDUS EXTRACT; PHYLLANTHUS NIRURI EXTRACT; PHYLLANTHUS PECTINATUS EXTRACT; PHYLLANTHUS ROSEUS EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG;

ARTICLE; BACCAUREA MOTLEYANA; BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; COLON CANCER; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG SCREENING; EPIDERMOID TUMOR; FEMALE; FRUIT; HUMAN; HUMAN CELL; IC 50; OVARY CANCER; PHYLLANTHUS; PHYLLANTHUS ACIDUS; PHYLLANTHUS NIRURI; PHYLLANTHUS PECTINATUS; PHYLLANTHUS ROSEUS; PLANT LEAF; SPECIES DIFFERENCE; UTERINE CERVIX CARCINOMA;

BACCAUREA; BACCAUREA MOTLEYANA; PECTINATUS; PHYLLANTHACEAE; PHYLLANTHUS (ANGIOSPERM); PHYLLANTHUS ACIDUS; PHYLLANTHUS NIRURI;

EID: 79959853275     PISSN: 19960875     EISSN: 19960875     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Aggarwal BB, Shishodia S (2006). Molecular targets of dietary agents for prevention and therapy of cancer. Biochem. Pharmacol., 71: 1397-1421.
2. Akanitapichat P, Wangmaneerat A, Teerawatanasuk N (2005). Anti-herpes Simplex Virus Type 1 activity of local Northeastern plants. Thai J. Pharm. Sci., 29(3/4): 137-145.
3. Ani S, Faizal M (2003). Nomenclature and equivalent names of Malaysian timbers. Timber Technol. Bull., 28: 20.
4. Borenfreund E, Puerner JA (1984). A simple quantitative procedure using monolayer culture for toxicity assays. J. Tiss. Cult. Meth., 9: 7-9.
5. Braverman IM (2002). Skin manifestations of internal malignanacy. Clinics. Geriatr. Med., 18(1): 1-19.
6. Burkill IH (1966). A Dictionary of the Economic Products of the Malay Peninsula. Ministry of Agriculture and Co. Operatives, Kuala Lumpur, Malaysia. Volume 2.
7. Calixto JB, Santos ARS, Filho VC, Yunes RA (1998). A review of the plants of the genus Phyllanthus: their chemistry, pharmacology, and therapeutic potential. Med. Res. Rev., 18(4): 225-258.
8. Chiang LC, Chiang W, Chang MY, Ng LT, Lin CC (2003). Antileukimic activity of selected natural products in Taiwan. Am. J. Chin. Med., 31: 37-46.
9. Chin HF (1986). Rambai and tampoi in Malaysia. Yearbook-West Australian Nut and Tree Crops Assoc., 11: 72-73.
10. Coussens LM, Werb Z (2002). Inflammation and cancer. Nat., 420(6917): 19-26.
11. Cragg GM, Newman DJ (2005). Plants as a source of anti-cancer agents. J. Ethnopharmacol., 100: 62-79.
12. Crowell PL, Gould MN (1994). Chemoprevention and therapy of cancer by d-limonene. CRC Crit. Rev. Oncol., 5: 1-22.
13. De Souza TP, Holzschuh MH, Lionço MI, Ortega GG, Petrovick PR (2002). Validation of LC methods for the analysis of phenolic compounds from aqueous extract of Phyllanthus niruri aerial parts. J. Pharm. Biomed. Anal., 30(2): 351-356.
14. Engel DH, Phummai S (2000). A Field Guide to Tropical Plants of Asia. Times Edition.
15. Fakim AG (2006). Medicinal plants: Traditions of yesterday and drugs of tomorrow. Mol. Aspects Med., 27: 1-93.
16. Geran RI, Greenberg NH, McDonald MM, Schumacher AM, Abbott BJ (1972). Protocols for screening chemical agents and natural products against animal tumor and other biological systems. Cancer Chemother. Rep., 3(2): 17-19.
17. Giridharan P, Somasundaram S, Perumal K, Vishwakarma RA, Karthikeyan NP, Velmurugan R, Balakrishnan A (2002). Novel substituted methylenedioxy lignan suppress proliferation of cancer cells by inhibiting telomerase and activation of c-myc and caspases leading apoptosis. Br. J. Cancer, 87: 98-105.
18. Harish R, Shivanandappa T (2006). Antioxidant activity and hepatoproctective potential of Phyllanthus niruri. Food Chem., 93: 180-185.
19. Harvey H (2000). Strategies for discovering drugs from previously unexplored natural products. Drug Discov. Today, 5: 294-300.
20. Hayes RB, Pottern LM, Strickler H, Rabkin C, Pope V, Swanson GM (2000). Sexual behaviour, STDs and risks for prostate cancer. Br. J. Cancer, 82(3): 718-725.
21. Huang ST, Yang RC, Lee PN, Yang SH, Liao SK, Chen TY, Pang JHS (2006). Anti-tumor and anti-angiogenic effects of Phyllanthus urinaria in mice bearing Lewis lung carcinoma. Int. Immunopharmacol., 6(6): 870-879.
22. Jagessar RC, Mars A, Gomes G (2008). Selective antimicrobial properties of Phyllanthus acidus leaf extract against Candida albicans, Escherichia coli and Staphylococcus aureus using stokes disc diffusion, well diffusion, streak plate and a dilution method. Nat. Sci., 6 (2): 24-38.
23. Jamia AJ (2006). Malay traditional medicine: An overview of scientific and technological progress. Tech. Monitor. Nov-Dec 2006: 37-49.
24. Jeena KJ, Joy KL, Kuttan R (1999). Effect of Emblica officinalis, Phyllanthus amarus and Picrorrhiza kurroa on N-nitrosodiethylamine induced hepatocarcinogenesis. Cancer Lett., 136(1): 11-16.
25. Kamaruddin MS, Latiff A (2002). Malaysian Medicinal Plants. University Kebangsaan Malaysia.
26. Khanna AK, Rizvi F, Chander R (2002). Lipid lowering activity of Phyllanthus niruri in hyperlipemic rats. J. Ethnopharmacol., 82(1): 19-22.
27. Khatoon S, Rai V, Rawat AKS, Mehrota S (2006). Comparative pharmacognostic studies of three Phyllanthus species. J. Ethnopharmacol., 104: 79-86.
28. Khazanah Endau Rompin Herba, (2007). Utusan Publications and Distributions.
29. Kiemer AK, Hartung T, Huber C, Vollmar AM (2003). Phyllanthus amarus has anti-inflammatory potential by inhibition of iNOS, COX-2, and cytokines via NF-κB pathway. J. Hepatol., 38(3): 289-297.
30. Kumaran A, Karunakaran RJ (2007). In vitro antioxidant activities of methanol extracts of five Phyllanthus species from India. LWT, 40: 344-352.
31. Leeya Y, Mulvany MJ, Queiroz EF, Marston A, Hostettmann K, Jansakul C (2010). Hypotensive activity of an n-butanol extract and their purified compounds from leaves of Phyllanthus acidus (L.) Skeels in rats. Eur. J. Pharmacol., 649: 301-313.
32. Leite DFP, Kassuya CAL, Mazzuco TL, Silvestre A, de Melo LV, Rehder VLG, Rumjanek VM, Calixto JB (2006). The cytotoxic effect and the multidrug resistance reversing action of lignans from Phyllanthus amarus. Planta Med., 72(15): 1353-1358.
33. Liu J, Lin H, McIntosh H (2001). Genus Phyllanthus for chronic hepatitis B virus infection: a systemic review. J. Viral Hepatitis, 8: 358-366.
34. Manez S, Recio, MC, Giner, RM, Luis Rios J (1997). Effect of selected triterpenoids on chronic dermal inflammation. Eur. J. Pharmacol., 334: 103-105.
35. McChesney JD, Venkataraman SK, Henri JT (2007). Plant natural products: Back to the future or into extinction?. Phytochem., 68: 2015-2022.
36. Muhamad Z, Mustafa AM (1998). Traditional Malay Medicinal Plants. Fajar Bakti Publication.
37. Murugaiyah V, Chan KL (2007). Determination of four lignans in Phyllanthus niruri L. by a simple high-performance liquid chromatography method with fluorescence detection. J. Chromatogr. A., 1154(1/2): 198-204.
38. Murugaiyah V, Chan KL (2009). Mechanisms of antihyperuricemic effects of Phyllanthus niruri and its lignan constituents. J. Ethnopharmacol., 124(2): 233-239.
39. Newman DJ, Cragg GM, Snader KM (2003). Natural products as sources of new drugs over the period 1981-2002. J. Nat. Prod., 66(7): 1022-1037.
40. Ng FSP (2000). The identity of the Melaka. Malaysian Naturalist, 53(3): 32-35.
41. Ong CY, Ling SK., Rasadah MA, Chee CF, Zainon AS, Ho ASH, Teo, SH, Lee HB (2009). Systematic analysis of in vitro photo-cytotoxic activity in extracts from terrestrial plants in Peninsula Malaysia for photodynamic therapy. J. Photochem. Photobiol. B: Biol., 96: 216-222.
42. Ong HC, Norzalina J (1999). Malay herbal medicine in Gemencheh, Negri Sembilan, Malaysia. Fitoterapia, 70: 10-14.
43. Perz JF, Armstrong GL, Farrington LA, Hutin YJF, Bell BP (2006). The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J. Hepatol., 45(4): 529-538.
44. Rajeshkumar NV, Joy KL, Girija K, Ramsewak RS, Nair MG, Ramadasan K (2002). Antitumour and anticarcinogenic activity of Phyllanthus amarus extract. J. Ethnopharmacol., 81:17-22.
45. Rajkapoor B, Sankari M, Sumithra M, Anbu J, Harikirishnan N, Gobinath M, Suba V, Balaji R (2007). Antitumor and cytotoxic effects of Phyllanthus polyphyllus on ehrlich ascites carcinoma and human cancer cell lines. Biosci. Biotechnol. Biochem., 71(9): 2177-2183.
46. Rocha AB, Lopes RM, Schwartsmann G (2001). Natural products in anticancer theraphy. Curr. Opin. Pharmacol., 1: 364-369.
47. Sabir SM, Rocha JBT (2008). Water-extractable phytochemicals from Phyllanthus niruri exhibit distinct in vitro antioxidant and in vivo hepatoprotective activity against paracetamol-induced liver damage in mice. Food Chem., 111(4): 845-851.
48. Salleh (1997). Ethnobotany, ethnopharmacognosy and documentation of Malaysia medicinal and aromatic plants. IDS Project Report: Biotechnology Application in Sabah 1998.
49. Samuel R, Kathriarachchi H, Hoffmann P, Barfuss MHJ, Wurdack KJ, Davis CC, Chase MW (2005). Molecular phylogenetics of Phyllanthaceae: Evidence from plastid MATK and nuclear PHYC sequences. Am. J. Bot., 92(1): 132-141.
50. Samy J, Sugumaran M, Lee KLW (2005). Herbs of Malaysia: An introduction to the medicinal, culinary, aromatic and cosmetic use of herbs. Times Edition.
51. Sanchez-Lamaz A, Fiore M, Cundari E, Rocordy R, Cozzi R, De Salvia R (1999). Phyllanthus orbicularis aqueous extract: Cytotoxic, genotoxic, and antimutagenic effects in the CHO cell line. Toxicol. Appl. Pharmacol., 161: 231-239.
52. holikhah EN, Mustofa, Wahyuono S (2004). Antiplasmodial and cytotoxic activities of extracts of meniran (Phyllanthus niruri) traditionally used to treat malaria in Indonesia. Clin. Exp. Pharmacol. Physiol., 31(1): A168-A169.
53. Singh B, Agarwal PK, Thakur RS (1989). An acyclic triterpene from Phyllanthus niruri. Phytochem., 28(7): 1980-1981.
54. Sousa M, Ousingsawat J, Seitz R, Puntheeranurak S, Regalado A, Schmidt A, Grego T, Jansakul C, Amaral MD, Schreiber R, Kunzelmann K (2007). An extract from medicinal plant Phyllanthus acidus and its isolated compounds induce airway chloride secretion: A potential treatment for cystic fibrosis. Mol. Pharmacol., 71(1): 366-376.
55. Suhaila M, Zahariah H, Norhashimah AH (1994). Antimicrobial activity of some tropical fruit wastes (Guava, starfruit, banana, papaya, passionfruit, langsat, duku, rambutan and rambai). Pertanika J. Trop. Agric. Sci., 17(3): 219-227.
56. Tuchinda P, Kornsakulkarn J, Pohmakotr M, Kongsaeree P, Prabpai S, Yoosook C, Kasisit J, Napaswad C, Sophasan S, Reutrakul V (2008). Dichapetalin-type triterpenoids and lignana from the aerial parts of Phyllanthus acutissima. J. Nat. Prod., 71(4): 655-663.
57. Verma M, Singh SK, Bhushan S, Sharma VK, Dalt P, Kapachi BK, Saxena AK (2008). In vitro potential of Polyalthia longifolia on human cancer cell lines and induction of apoptosis through mitochondrialdependent pathway in HL-60 cells. Chem-Biol. Interact., 171: 45-56.
58. Vongvanich N, Kittakoop P, Kramyu J, Tantichareon M, Thebtaranonth M (2000). Phyllanthusols A and B, cytotoxic norbisabolane glycosides from Phyllanthus acidus Skeels. J. Org. Chem., 65: 5420-5423.
59. Wada SI, Iida A, Tanaka R (2001). Screening of triterpenoids isolated from Phyllanthus flexuosus for DNA topoisomerase inhibitory activity. J. Nat. Prod., 64(12): 1545-1547.
60. Werner R (2002). Medicines in Malay Village. University Malaya Press.
61. Zhang YJ, Nagao T, Tanaka T, Yang CR, Okabe H, Kouno I (2004). Antiproliferative activity of the main constituents from Phyllanthus emblica. Biol. Pharm. Bull., 27(2): 251-255.